Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis

BACKGROUND: Biologic disease-modifying antirheumatic drugs (DMARDs) are increasingly used for rheumatoid arthritis (RA) treatment. However, little is known based on contemporary data about the factors associated with DMARDs and patterns of use of biologic DMARDs for initial and subsequent RA treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yinzhu, Desai, Rishi J., Liu, Jun, Choi, Nam-Kyong, Kim, Seoyoung C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499035/
https://www.ncbi.nlm.nih.gov/pubmed/28679392
http://dx.doi.org/10.1186/s13075-017-1366-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499035/
https://www.ncbi.nlm.nih.gov/pubmed/28679392
http://dx.doi.org/10.1186/s13075-017-1366-1

Ejemplares similares